The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC: BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. The approval ...
Highlights REAL’ aims to spark vital conversations about advanced prostate cancer and educate about the importance of ...
Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumors expressing Glypican-3 ...
The Brigham Young University student rocketeers blasted their way into history today, setting a new GUINNESS WORLD RECORDS title for Highest launch of an Alka-Rocket* in the 2018 Bayer Alka-Rocket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results